Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.44 |
| ▸ | ATM | Q13315 | 6/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6719494 | 0.87 | MAPT (0.50) | MAPTKMT2AHTTPOLBMEN1 | |
| SCHEMBL15601909 | 0.79 | MAPT (0.53) | MAPTKMT2AHTTPOLBMEN1 | |
| SCHEMBL5779764 | 0.78 | KMT2A (0.52) | MAPTKMT2AHTTPOLBMEN1 | |
| SCHEMBL5565031 | 0.78 | CNR1 (0.55) | MAPTKMT2AHTTPOLBMEN1 | |
| SCHEMBL2597849 | 0.76 | HTT (0.64) | MAPTKMT2AHTTPOLBMEN1 | |
| SCHEMBL6719504 | 0.76 | MAPT (0.49) | MAPTKMT2AHTTPOLBMEN1 | |
| SCHEMBL5565500 | 0.75 | MAPT (0.48) | MAPTKMT2AHTTPOLBMEN1 | |
| SCHEMBL6719499 | 0.75 | HTT (0.50) | MAPTKMT2AHTTPOLBMEN1 | |
| SCHEMBL5565491 | 0.74 | MEN1 (0.46) | MAPTKMT2AHTTPOLBMEN1 | |
| SCHEMBL5566673 | 0.73 | SMN1; SMN2 (0.49) | MAPTKMT2AHTTPOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7229479-B2 | Method of coloring porous material | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-06-12 | — | — | US | disclosed |
| US-20060162095-A1 | Method of colouring porous material | CIBA SPECIALTY CHEMICALS CORP. | 2006-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060162095-A1 | Method of colouring porous material | ACR, HLA-C, TYR | MAPT 2284/4885KMT2A 3603/4885HTT 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.